Status | Study |
Recruiting |
Study Name: MRI and Orbital Tumours (MEDORT) Condition: Orbital Tumor Orbital Pseudotumor Date: 2015-03-17 Interventions: Other: MRI |
Completed |
Study Name: Rituximab in IgG4-related Disease: A Phase 1-2 Trial Condition: Retroperitoneal Fibrosis Autoimmune Pancreatitis Sialadeni Date: 2012-04-22 Interventions: Drug: Rituximab Rituximab 1000 mg IV times two doses, separated by approximately 15 days. |
Active, not recruiting |
Study Name: Survey of Patients With Idiopathic Orbital Inflammation Syndrome Condition: Orbital Ischemic Syndrome Orbital Pseudotumor Date: 2011-06-15 |